User profiles for Marc Gotkine

Marc Gotkine

Hadassah University Hospital, Jerusalem, Israel
Verified email at gotkine.com
Cited by 3066

Potential roles of gut microbiome and metabolites in modulating ALS in mice

…, L Arike, MEV Johansson, GC Hansson, M Gotkine… - Nature, 2019 - nature.com
Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disorder, in which the
clinical manifestations may be influenced by genetic and unknown environmental factors. …

Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 …

P Petrou, Y Gothelf, Z Argov, M Gotkine, YS Levy… - JAMA …, 2016 - jamanetwork.com
Importance Preclinical studies have shown that neurotrophic growth factors (NTFs) extend
the survival of motor neurons in amyotrophic lateral sclerosis (ALS) and that the combined …

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

…, A Nordin, Y Lerner, M Zabari, M Gotkine… - Nature …, 2021 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk
of one in 350 people and an unmet need for disease-modifying therapies. We conducted a …

[PDF][PDF] Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia

…, N Atassi, DJ Lange, DJ Adams, L Stefanis, M Gotkine… - Cell reports, 2019 - cell.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
the progressive loss of motor neurons. While several pathogenic mutations have been …

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

…, M Brunetti, M Grassano, M Gotkine… - Science translational …, 2022 - science.org
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an estimated
heritability between 40 and 50%. DNA methylation patterns can serve as proxies of (past) …

Association of variants in the SPTLC1 gene with juvenile amyotrophic lateral sclerosis

…, A Calvo, G Mora, H Al-Saif, M Gotkine… - JAMA …, 2021 - jamanetwork.com
Importance Juvenile amyotrophic lateral sclerosis (ALS) is a rare form of ALS characterized
by age of symptom onset less than 25 years and a variable presentation. Objective To …

[PDF][PDF] Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis

…, P Couratier, O Hardiman, R McLaughin, M Gotkine… - Neuron, 2022 - cell.com
Amyotrophic lateral sclerosis (ALS) is a complex disease that leads to motor neuron death.
Despite heritability estimates of 52%, genome-wide association studies (GWASs) have …

Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein

…, M Benatar, JP Taylor, M Nalls, M Gotkine… - Nature …, 2019 - nature.com
To discover novel genes underlying amyotrophic lateral sclerosis (ALS), we aggregated
exomes from 3,864 cases and 7,839 ancestry-matched controls. We observed a significant …

Description of 3 patients with myasthenia gravis and COVID-19

…, Z Argov, A Vaknin-Dembinsky, M Gotkine - Journal of the …, 2020 - Elsevier
Background The COVID-19 pandemic presents two main concerns for patients with
myasthenia gravis (MG); chronic immunosuppression may put them at greater risk, and some …

Emergent stenting to treat patients with carotid artery dissection: clinically and radiologically directed therapeutic decision making

JE Cohen, RR Leker, M Gotkine, M Gomori, T Ben-Hur - Stroke, 2003 - Am Heart Assoc
Background and Purpose— Carotid artery dissection (CAD) is a common cause of stroke in
young patients. Clots formed at the low-flow zone in the false arterial lumen may give rise to …